Cite
HARVARD Citation
Akizawa, T. et al. (2020). Intermittent Oral Dosing of Roxadustat in Peritoneal Dialysis Chronic Kidney Disease Patients with Anemia: A Randomized, Phase 3, Multicenter, Open‐Label Study. Therapeutic apheresis and dialysis. 24 (2), pp. 115-125. [Online].